Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.
Published July 30, 2014 · Recall initiated: July 11, 2014
Summary
FDA records drug Class III recall D-1445-2014, published July 30, 2014 and initiated July 11, 2014. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 781,000 extended release tablets; Lot: Lot # DM1316; Exp. 05/16 Lot # DM1318; Exp. 05/16. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if ORPHENADRINE CITRATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ORPHENADRINE CITRATE
- Manufacturer
- Sandoz Inc
- Distributor
- Nationwide
- Lot
- Lot # DM1316; Exp. 05/16 Lot # DM1318; Exp. 05/16
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOrphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, Manufactured by Sandoz Inc.,April 13, 2022
- FDAClonidine HCl Injection, 1000 mcg/10 mL (100 mcg/mL),10 mL Single Dose Vial, Rx only, Manufactured for: X-GenJuly 30, 2014
- FDATaztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: ShamrockJuly 30, 2014
- FDAOxycodone HCl Oral Concentrate, 20 mg/mL, Rx (C-II) Packaged and labeled as Morphine Sulfate 20 mg/mL, Mfg:July 30, 2014
- FDATitan T 5K Motor Product Usage: Low-speed motor is used with various attachments to perform a variety ofJuly 23, 2014
- FDASpacelabs Healthcare Ultraview SL Multigas Module, Model 92518 (Software V1.00.00-09). Provides a means ofJuly 23, 2014
Questions about this recall
Was Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540. recalled?
Yes. FDA published recall D-1445-2014 on July 30, 2014. Reported hazard: Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ORPHENADRINE CITRATE.